<!DOCTYPE html>
<html lang="ko">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biomarker Panels</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 100vh;
            padding: 40px 20px;
        }
        
        .container {
            width: 960px;
            padding: 35px 45px;
            background: white;
        }
        
        .title {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 25px;
            text-align: center;
        }
        
        .features-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
        }
        
        .feature-card {
            background: #f8fbff;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 15px 18px;
            transition: all 0.3s;
        }
        
        .feature-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 6px 20px rgba(30, 100, 200, 0.2);
        }
        
        .feature-title {
            font-size: 17px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 8px;
        }
        
        .feature-desc {
            font-size: 16px;
            color: #333;
            line-height: 1.5;
        }
        
        .detailed-section {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 3px solid #1E64C8;
        }
        
        .section {
            margin-bottom: 45px;
            padding: 25px;
            background: #f8fbff;
            border-radius: 12px;
            border-left: 5px solid #1E64C8;
        }
        
        .section-title {
            font-size: 22px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 15px;
        }
        
        .section-content {
            font-size: 16px;
            color: #333;
            line-height: 1.8;
            margin-bottom: 20px;
        }
        
        .illustration {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 30px;
            margin: 20px 0;
            text-align: center;
        }
        
        .diagram {
            margin: 20px 0;
        }
        
        .box {
            display: inline-block;
            padding: 12px 20px;
            margin: 8px;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            background: white;
            font-weight: 600;
            color: #1E64C8;
        }
        
        .arrow {
            display: inline-block;
            margin: 0 10px;
            font-size: 24px;
            color: #1E64C8;
        }
        
        .example-box {
            background: #fff3cd;
            border-left: 4px solid #ffc107;
            padding: 15px;
            margin: 15px 0;
            border-radius: 5px;
        }
        
        .example-title {
            font-weight: 700;
            color: #856404;
            margin-bottom: 8px;
        }
        
        .table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
        }
        
        .table th {
            background: #1E64C8;
            color: white;
            padding: 12px;
            text-align: left;
            font-weight: 600;
        }
        
        .table td {
            border: 1px solid #ddd;
            padding: 10px;
            background: white;
        }
        
        .highlight {
            background: #e3f2fd;
            padding: 2px 6px;
            border-radius: 3px;
            font-weight: 600;
        }
        
        .flowchart {
            display: flex;
            justify-content: center;
            align-items: center;
            flex-wrap: wrap;
            gap: 10px;
            margin: 20px 0;
        }
        
        .flow-box {
            padding: 15px 25px;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            background: white;
            font-weight: 600;
            color: #1E64C8;
            min-width: 150px;
            text-align: center;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Biomarker Panels</div>
        
        <div class="features-grid">
            
            <div class="feature-card">
                <div class="feature-title">Multi-analyte Tests</div>
                <div class="feature-desc">Combining multiple biomarkers</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Optimal Combinations</div>
                <div class="feature-desc">Feature selection for panels</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Performance Metrics</div>
                <div class="feature-desc">Sensitivity, specificity, PPV, NPV</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Cost-benefit</div>
                <div class="feature-desc">Clinical and economic considerations</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">Regulatory Approval</div>
                <div class="feature-desc">FDA/EMA approval pathways</div>
            </div>
        
        </div>
        
        <div class="detailed-section">
            
            <!-- Section 1: Multi-analyte Tests -->
            <div class="section">
                <div class="section-title">1. Multi-analyte Tests</div>
                <div class="section-content">
                    Multi-analyte tests combine multiple biomarkers into a single assay to improve diagnostic accuracy and provide comprehensive disease assessment. This approach leverages complementary information from different biological pathways to enhance clinical decision-making.
                </div>
                
                <div class="illustration">
                    <div class="diagram">
                        <div class="box">Biomarker A<br>(Inflammation)</div>
                        <div class="box">Biomarker B<br>(Metabolism)</div>
                        <div class="box">Biomarker C<br>(Genetic)</div>
                        <div style="margin: 20px 0; font-size: 30px; color: #1E64C8;">⬇</div>
                        <div class="box" style="background: #1E64C8; color: white; padding: 15px 30px;">
                            Integrated Panel Score
                        </div>
                        <div style="margin: 20px 0; font-size: 30px; color: #1E64C8;">⬇</div>
                        <div class="box" style="background: #28a745; color: white;">
                            Enhanced Diagnostic Accuracy
                        </div>
                    </div>
                </div>
                
                <div class="example-box">
                    <div class="example-title">Clinical Example: Cardiac Risk Panel</div>
                    <div>
                        <strong>Traditional:</strong> Single marker (Total Cholesterol)<br>
                        <strong>Multi-analyte Panel:</strong> LDL, HDL, Triglycerides, hsCRP, Troponin, BNP<br>
                        <strong>Benefit:</strong> Improved risk stratification from 60% to 85% accuracy
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>Key Advantages:</strong><br>
                    • Increased sensitivity and specificity compared to single biomarkers<br>
                    • Ability to detect multiple disease states simultaneously<br>
                    • Reduced false positive and false negative rates<br>
                    • Comprehensive assessment of disease mechanisms
                </div>
            </div>
            
            <!-- Section 2: Optimal Combinations -->
            <div class="section">
                <div class="section-title">2. Optimal Combinations</div>
                <div class="section-content">
                    Selecting the optimal combination of biomarkers is crucial for panel development. Feature selection algorithms identify the most informative biomarkers while minimizing redundancy and complexity.
                </div>
                
                <div class="illustration">
                    <div class="diagram">
                        <div style="margin-bottom: 20px;">
                            <div class="box" style="background: #e9ecef;">Candidate Biomarkers (n=50)</div>
                        </div>
                        <div class="flowchart">
                            <div class="flow-box">Statistical Analysis</div>
                            <span class="arrow">→</span>
                            <div class="flow-box">Correlation Study</div>
                            <span class="arrow">→</span>
                            <div class="flow-box">Machine Learning</div>
                        </div>
                        <div style="margin: 20px 0; font-size: 30px; color: #1E64C8;">⬇</div>
                        <div class="box" style="background: #28a745; color: white;">
                            Optimized Panel (n=5-10)
                        </div>
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>Selection Methods:</strong>
                </div>
                
                <table class="table">
                    <tr>
                        <th>Method</th>
                        <th>Approach</th>
                        <th>Application</th>
                    </tr>
                    <tr>
                        <td><span class="highlight">Univariate Analysis</span></td>
                        <td>Individual marker performance</td>
                        <td>Initial screening</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">Multivariate Models</span></td>
                        <td>Logistic regression, Cox models</td>
                        <td>Risk prediction</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">Machine Learning</span></td>
                        <td>Random forests, SVM, Neural networks</td>
                        <td>Complex pattern recognition</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">LASSO/Ridge</span></td>
                        <td>Penalized regression</td>
                        <td>Feature reduction</td>
                    </tr>
                </table>
                
                <div class="example-box">
                    <div class="example-title">Example: Cancer Detection Panel</div>
                    <div>
                        <strong>Initial candidates:</strong> 50 protein markers<br>
                        <strong>After correlation analysis:</strong> 20 independent markers<br>
                        <strong>After ML optimization:</strong> 7-marker panel<br>
                        <strong>Result:</strong> 92% sensitivity, 95% specificity
                    </div>
                </div>
            </div>
            
            <!-- Section 3: Performance Metrics -->
            <div class="section">
                <div class="section-title">3. Performance Metrics</div>
                <div class="section-content">
                    Evaluating biomarker panel performance requires multiple metrics to assess clinical utility. These metrics help determine the panel's ability to correctly identify disease presence or absence.
                </div>
                
                <div class="illustration">
                    <table class="table">
                        <tr>
                            <th colspan="2" rowspan="2" style="background: white;"></th>
                            <th colspan="2" style="text-align: center;">Disease Status</th>
                        </tr>
                        <tr>
                            <th style="text-align: center;">Positive</th>
                            <th style="text-align: center;">Negative</th>
                        </tr>
                        <tr>
                            <th rowspan="2">Test Result</th>
                            <th>Positive</th>
                            <td style="background: #d4edda; text-align: center; font-weight: 700;">True Positive (TP)</td>
                            <td style="background: #f8d7da; text-align: center; font-weight: 700;">False Positive (FP)</td>
                        </tr>
                        <tr>
                            <th>Negative</th>
                            <td style="background: #f8d7da; text-align: center; font-weight: 700;">False Negative (FN)</td>
                            <td style="background: #d4edda; text-align: center; font-weight: 700;">True Negative (TN)</td>
                        </tr>
                    </table>
                </div>
                
                <div class="section-content">
                    <strong>Key Performance Metrics:</strong>
                </div>
                
                <table class="table">
                    <tr>
                        <th>Metric</th>
                        <th>Formula</th>
                        <th>Clinical Meaning</th>
                        <th>Target</th>
                    </tr>
                    <tr>
                        <td><span class="highlight">Sensitivity</span></td>
                        <td>TP / (TP + FN)</td>
                        <td>Ability to detect disease</td>
                        <td>&gt;90%</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">Specificity</span></td>
                        <td>TN / (TN + FP)</td>
                        <td>Ability to rule out disease</td>
                        <td>&gt;90%</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">PPV</span></td>
                        <td>TP / (TP + FP)</td>
                        <td>Probability of disease if test positive</td>
                        <td>&gt;80%</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">NPV</span></td>
                        <td>TN / (TN + FN)</td>
                        <td>Probability of no disease if test negative</td>
                        <td>&gt;95%</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">AUC-ROC</span></td>
                        <td>Area under curve</td>
                        <td>Overall discrimination ability</td>
                        <td>&gt;0.85</td>
                    </tr>
                </table>
                
                <div class="example-box">
                    <div class="example-title">Example: Breast Cancer Screening Panel</div>
                    <div>
                        Study population: 1,000 women (100 with cancer)<br>
                        Test results: 95 TP, 5 FN, 810 TN, 90 FP<br>
                        <strong>Sensitivity:</strong> 95% (95/100)<br>
                        <strong>Specificity:</strong> 90% (810/900)<br>
                        <strong>PPV:</strong> 51.4% (95/185)<br>
                        <strong>NPV:</strong> 99.4% (810/815)
                    </div>
                </div>
            </div>
            
            <!-- Section 4: Cost-benefit -->
            <div class="section">
                <div class="section-title">4. Cost-benefit Analysis</div>
                <div class="section-content">
                    Clinical and economic considerations are essential for successful panel implementation. Cost-effectiveness analysis balances diagnostic performance with healthcare resource utilization.
                </div>
                
                <div class="illustration">
                    <div class="diagram">
                        <div class="flowchart" style="flex-direction: column;">
                            <div style="display: flex; gap: 20px; margin: 10px 0;">
                                <div class="flow-box" style="background: #fff3cd;">Test Cost</div>
                                <div class="flow-box" style="background: #fff3cd;">Reagent Cost</div>
                                <div class="flow-box" style="background: #fff3cd;">Labor Cost</div>
                            </div>
                            <div style="font-size: 30px; color: #1E64C8; margin: 10px 0;">⬇</div>
                            <div class="flow-box" style="background: #1E64C8; color: white; min-width: 300px;">
                                Total Direct Costs
                            </div>
                            <div style="font-size: 30px; color: #1E64C8; margin: 10px 0;">VS</div>
                            <div style="display: flex; gap: 20px; margin: 10px 0;">
                                <div class="flow-box" style="background: #d4edda;">Early Detection</div>
                                <div class="flow-box" style="background: #d4edda;">Prevent Complications</div>
                                <div class="flow-box" style="background: #d4edda;">Improved Outcomes</div>
                            </div>
                            <div style="font-size: 30px; color: #28a745; margin: 10px 0;">⬇</div>
                            <div class="flow-box" style="background: #28a745; color: white; min-width: 300px;">
                                Healthcare Savings
                            </div>
                        </div>
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>Economic Evaluation Components:</strong>
                </div>
                
                <table class="table">
                    <tr>
                        <th>Category</th>
                        <th>Cost Factors</th>
                        <th>Benefit Factors</th>
                    </tr>
                    <tr>
                        <td><span class="highlight">Direct Medical</span></td>
                        <td>Test materials, equipment, personnel</td>
                        <td>Avoided hospitalizations, reduced treatment costs</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">Indirect</span></td>
                        <td>Follow-up tests, false positive workup</td>
                        <td>Improved productivity, reduced disability</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">Intangible</span></td>
                        <td>Patient anxiety, waiting time</td>
                        <td>Quality of life, peace of mind</td>
                    </tr>
                </table>
                
                <div class="example-box">
                    <div class="example-title">Example: Cardiovascular Risk Panel</div>
                    <div>
                        <strong>Panel cost:</strong> $200 per test<br>
                        <strong>Population:</strong> 10,000 high-risk patients<br>
                        <strong>Total testing cost:</strong> $2,000,000<br>
                        <strong>Prevented MI/Stroke:</strong> 150 events<br>
                        <strong>Average treatment cost saved:</strong> $50,000 per event<br>
                        <strong>Total savings:</strong> $7,500,000<br>
                        <strong>Net benefit:</strong> $5,500,000 (ROI: 275%)
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>Clinical Considerations:</strong><br>
                    • Impact on treatment decisions and patient outcomes<br>
                    • Integration into existing clinical workflows<br>
                    • Training requirements for healthcare providers<br>
                    • Patient acceptance and compliance
                </div>
            </div>
            
            <!-- Section 5: Regulatory Approval -->
            <div class="section">
                <div class="section-title">5. Regulatory Approval</div>
                <div class="section-content">
                    Biomarker panels must navigate complex regulatory pathways to reach clinical use. FDA and EMA approval processes ensure safety, efficacy, and clinical validity.
                </div>
                
                <div class="illustration">
                    <div class="diagram">
                        <div class="flowchart" style="flex-direction: column;">
                            <div class="flow-box" style="min-width: 300px;">Discovery & Development</div>
                            <div style="font-size: 30px; color: #1E64C8;">⬇</div>
                            <div class="flow-box" style="min-width: 300px;">Analytical Validation</div>
                            <div style="font-size: 30px; color: #1E64C8;">⬇</div>
                            <div class="flow-box" style="min-width: 300px;">Clinical Validation</div>
                            <div style="font-size: 30px; color: #1E64C8;">⬇</div>
                            <div class="flow-box" style="min-width: 300px;">Regulatory Submission</div>
                            <div style="font-size: 30px; color: #1E64C8;">⬇</div>
                            <div class="flow-box" style="background: #28a745; color: white; min-width: 300px;">Market Approval</div>
                            <div style="font-size: 30px; color: #1E64C8;">⬇</div>
                            <div class="flow-box" style="min-width: 300px;">Post-market Surveillance</div>
                        </div>
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>FDA Approval Pathways:</strong>
                </div>
                
                <table class="table">
                    <tr>
                        <th>Pathway</th>
                        <th>Description</th>
                        <th>Timeline</th>
                        <th>Examples</th>
                    </tr>
                    <tr>
                        <td><span class="highlight">510(k) Clearance</span></td>
                        <td>Substantially equivalent to existing device</td>
                        <td>3-6 months</td>
                        <td>Routine diagnostic panels</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">De Novo</span></td>
                        <td>Novel low-to-moderate risk devices</td>
                        <td>6-12 months</td>
                        <td>New biomarker combinations</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">PMA</span></td>
                        <td>High-risk devices requiring clinical trials</td>
                        <td>1-3 years</td>
                        <td>Cancer screening panels</td>
                    </tr>
                    <tr>
                        <td><span class="highlight">LDT</span></td>
                        <td>Laboratory Developed Tests (CLIA-certified)</td>
                        <td>Variable</td>
                        <td>Specialty laboratory tests</td>
                    </tr>
                </table>
                
                <div class="example-box">
                    <div class="example-title">Example: Oncotype DX (Breast Cancer Panel)</div>
                    <div>
                        <strong>Type:</strong> 21-gene expression panel<br>
                        <strong>Pathway:</strong> Initially LDT, later FDA De Novo approval<br>
                        <strong>Clinical validation:</strong> Multiple prospective studies (10,000+ patients)<br>
                        <strong>Evidence required:</strong> Analytical validity, clinical validity, clinical utility<br>
                        <strong>Result:</strong> FDA approval + Medicare coverage
                    </div>
                </div>
                
                <div class="section-content">
                    <strong>Key Regulatory Requirements:</strong><br>
                    • <span class="highlight">Analytical Validation:</span> Accuracy, precision, sensitivity, specificity, reproducibility<br>
                    • <span class="highlight">Clinical Validation:</span> Association with clinical outcomes in target population<br>
                    • <span class="highlight">Clinical Utility:</span> Impact on patient management and health outcomes<br>
                    • <span class="highlight">Quality Systems:</span> Manufacturing, quality control, documentation<br>
                    • <span class="highlight">Labeling:</span> Intended use, limitations, interpretation guidance
                </div>
                
                <div class="section-content">
                    <strong>EMA Approval (European Union):</strong><br>
                    • In Vitro Diagnostic Regulation (IVDR) - implemented 2022<br>
                    • Risk classification: Class A (lowest) to Class D (highest)<br>
                    • CE marking required for market access<br>
                    • Notified Body assessment for higher-risk devices<br>
                    • Post-market surveillance and vigilance reporting
                </div>
            </div>
            
        </div>
    </div>
</body>
</html>